IART.NASDAQIntegra Lifesciences Holdings CORP

Form 4: Integra LifeSciences SVP Mosebrook Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing

📋All filings for Integra Lifesciences Holdings CORP
🔒Login to Follow

Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences, reports transactions involving common stock, including acquisitions and disposals to cover tax obligations.

Summary

  • Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences Holdings Corp, filed a Form 4 detailing changes in beneficial ownership.
  • On March 11, 2024, 130 shares of common stock were disposed of at a price of $36.22.
  • Also on March 11, 2024, 3,410 shares of common stock were acquired at a price of $0.
  • On March 12, 2024, 223 shares of common stock were disposed of at a price of $35.88.
  • On March 12, 2024, 124 shares of common stock were disposed of at a price of $35.88.
  • Following these transactions, Mosebrook directly owns 26,923 shares of Integra LifeSciences common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.

Positives

  • The reporting person acquired 3,410 shares of common stock on March 11, 2024.

Negatives

  • A total of 477 shares were disposed of to cover tax obligations.

Industry Context

This filing is a routine disclosure related to insider trading regulations and provides transparency into the transactions of company executives.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership.

Key Dates

DateDescription
03/11/2024Disposal of 130 shares of common stock at $36.22 and acquisition of 3,410 shares at $0.
03/12/2024Disposal of 223 shares and 124 shares of common stock at $35.88.
03/13/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.